Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
Prof David Jones, MD†, Dr Pol F Boudes , Prof Mark G Swain, MD, Prof Christopher L Bowlus, MD, Michael R Galambos, MD , Prof Bruce R Bacon, MD , Prof Yvonne Doerffel, MD , Prof Norman Gitlin, MD , Stuart C Gordon, MD , Joseph A Odin, MD , David Sheridan, MD , Prof Markus-Alexander Wörns, MD, Virginia Clark, MD, Linsey Corless, MD, Prof Heinz Hartmann, MD, Mark E Jonas, MD, Andreas E Kremer, MD, George F Mells, MD, Peter Buggisch, MD, Bradley L Freilich, MD,